Managers / Q3 2019 · view latest →
Phoenix Financial Ltd.
CIK 0001679543 · 53 DERECH HA'SHALOM ST., GIVATAYIM, 53454 · 972-3-733-2997
Summary
Phoenix Financial Ltd. reported $2.1B in U.S.-listed holdings across 239 positions for Q3 2019.
Its largest position, Mylan N V, represents 2.7% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 58.9% · $1.2B
- Other · 29.5% · $622M
- ADR · 7.1% · $150M
- ETP · 4.5% · $95M
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TOWER SEMICONDUCTOR LTD | NEW | +3.30M | 3.30M | +$60M | $60M |
| MYLAN N V | NEW | +3.00M | 3.00M | +$57M | $57M |
| SEDGSOLAREDGE TECHNOLOGIES INC | NEW | +653.6K | 653.6K | +$52M | $52M |
| GOOGALPHABET INC | NEW | +41.8K | 41.8K | +$49M | $49M |
| HNMORMAT TECHNOLOGIES INC | NEW | +668.7K | 668.7K | +$48M | $48M |
| 4I1PHILIP MORRIS INTL INC | NEW | +511.5K | 511.5K | +$37M | $37M |
| TEVATEVA PHARMACEUTICAL INDS LTD | NEW | +5.23M | 5.23M | +$34M | $34M |
| RADWARE LTD | NEW | +1.48M | 1.48M | +$34M | $34M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $10.5B | 691 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $9.2B | 671 | Feb 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025REVEALED | $15.7B | 1,272 | Nov 13, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2025 | $7.6B | 614 | Jul 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $6.5B | 536 | May 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $7.3B | 522 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $6.8B | 524 | Nov 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $6.6B | 507 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $7.2B | 598 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $6.0B | 482 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $5.4B | 401 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $4.9B | 370 | Aug 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $4.5B | 339 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $5.2B | 367 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $4.5B | 463 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $4.9B | 529 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $5.9B | 546 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $6.1B | 501 | Feb 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $5.8B | 521 | Oct 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $5.3B | 405 | Aug 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $4.4B | 514 | May 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $3.7B | 449 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.4B | 399 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $2.4B | 408 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $2.0B | 389 | May 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.4B | 240 | Feb 18, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $2.1B | 239 | Nov 18, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Excellence Investments Ltd.028-18651
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.